Cross-sectional and prospective relationships of apoA-I and apoB100 with subclinical atherosclerosis

我们已经完全完成了我们的研究血清apoA 1和apoB和亚临床动脉粥样硬化的测量。我们已经发现，载脂蛋白A1和载脂蛋白B与颈动脉内膜中层厚度，亚临床动脉粥样硬化的标志物有显着的关系。然而，这些关系依赖于它们的脂质对应物：HDL-P和LDL-P。在我们的纵向分析中，我们没有发现载脂蛋白水平的变化与冠状动脉亚临床动脉粥样硬化临床改善的证据之间有任何显着的关系。载脂蛋白A1和载脂蛋白B与总agatston评分的变化均无显著相关性。我们希望尽快提交给国际SCI期刊，如Atheroscopy，ATVB和Heart。

We have fully completed our study on serum measurements of apoA1 and apoB and subclinical atherosclerosis. We have found that both apoA1 and apoB have significant relationships with carotid intima-media thickness, a marker of subclinical atherosclerosis. These relationships, however, are dependent on their lipid counterparts: HDL-P and LDL-P.In our longitudinal analyses, we could not find any significant relationship between the changes in apoprotein levels and evidence of clinical improvements in coronary subclinical atherosclerosis. Neither apoA1, nor apoB was significantly related to changes in total agatston score.We are currently in the manuscript write-up stage of this study. We hope to soon submit to International SCI journals, such as Atherosclerosis, ATVB and Heart.